The Journal of Immunology, Vol 155, Issue 3 1404-1410, Copyright © 1995 by American Association of Immunologists

ARTICLES

The serine/threonine phosphatase inhibitor, calyculin A, inhibits and dissociates macrophage responses to lipopolysaccharide

SA Barber, PY Perera, R McNally and SN Vogel
Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

LPS-stimulated macrophages (M phi) produce inflammatory mediators that are largely responsible for the pathophysiology associated with septic shock. M phi respond to LPS with rapid protein phosphorylation and dephosphorylation on serine, threonine, and tyrosine residues. If these events are critical for the cellular response to LPS, the kinases and/or phosphatases involved may be vulnerable targets for pharmacologic intervention. Recent studies demonstrated that tyrosine kinase inhibitors block LPS-induced tyrosine phosphorylation of MAP kinases as well as TNF-alpha and IL-1 beta production. To investigate a role for serine/threonine phosphatases, we evaluated the effect of calyculin A, a potent serine/threonine phosphatase inhibitor, on LPS stimulation of murine M phi. Pretreatment of M phi with calyculin A inhibited LPS-induced expression of six immediate-early genes: TNF- alpha, IL-1 beta, IFN-beta, IP-10, IRF-1, and TNFR-2. Calyculin A added 1.5 h after LPS treatment greatly reduced accumulation of IP-10, IRF-1, and TNFR-2 mRNA, but not TNF-alpha, IL-1 beta, and IFN-beta mRNA. Calyculin A, in the absence or presence of LPS, resulted in sustained tyrosine phosphorylation of the MAP kinases. These findings suggest that an "early" serine/threonine phosphatase activity is essential for LPS stimulation of M phi and that the activation of MAP kinases is not sufficient for the induction of these immediate-early genes. The requirement for a "late" phosphatase activity for expression of a subset of LPS-inducible genes dissociates at least two regulatory pathways in LPS signal transduction.

This article has been cited by other articles:

				S. A. Barber, J. L. Uhrlaub, J. B. DeWitt, P. M. Tarwater, and M. C. Zink Dysregulation of Mitogen-Activated Protein Kinase Signaling Pathways in Simian Immunodeficiency Virus Encephalitis Am. J. Pathol., February 1, 2004; 164(2): 355 - 362. [Abstract] [Full Text] [PDF]

				J. J. Watters, J. A. Sommer, Z. A. Pfeiffer, U. Prabhu, A. N. Guerra, and P. J. Bertics A Differential Role for the Mitogen-activated Protein Kinases in Lipopolysaccharide Signaling. THE MEK/ERK PATHWAY IS NOT ESSENTIAL FOR NITRIC OXIDE AND INTERLEUKIN 1beta PRODUCTION J. Biol. Chem., March 8, 2002; 277(11): 9077 - 9087. [Abstract] [Full Text] [PDF]

				E. Rollet-Labelle, C. Gilbert, and P. H. Naccache Modulation of Human Neutrophil Responses to CD32 Cross-Linking by Serine/Threonine Phosphatase Inhibitors: Cross-Talk Between Serine/Threonine and Tyrosine Phosphorylation J. Immunol., January 15, 2000; 164(2): 1020 - 1028. [Abstract] [Full Text] [PDF]

				Y.-T. Juang, W.-C. Au, W. Lowther, J. Hiscott, and P. M. Pitha Lipopolysaccharide Inhibits Virus-mediated Induction of Interferon Genes by Disruption of Nuclear Transport of Interferon Regulatory Factors 3 and 7 J. Biol. Chem., June 18, 1999; 274(25): 18060 - 18066. [Abstract] [Full Text] [PDF]

				B. K. Yoza, J. D. Wells, and C. E. McCall Clin. Vaccine Immunol., May 1, 1998; 5(3): 281 - 287. [Abstract] [Full Text]

				S.A. Barber, C.A. Salkowski, M.J. Fultz, P-Y. Perera, R. McNally, and S.N. Vogel Regulation of gene expression and nitric oxide production in murine macrophages by the serine/threonine phosphatase inhibitor okadaic acid Innate Immunity, February 1, 1996; 3(1): 19 - 27. [Abstract] [PDF]